Are you Dr. Chen?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 28 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Summary
- Dr. Christopher Chen, MD is a board certified internist in Stanford, California. He is currently licensed to practice medicine in California and Massachusetts. He is affiliated with Stanford Health Care.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2020
- Massachusetts General HospitalResidency, Internal Medicine, 2014 - 2017
- Washington University in St. Louis School of MedicineClass of 2014
Certifications & Licensure
- CA State Medical License 2020 - 2026
- MA State Medical License 2014 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid Tumors.Christopher T Chen, Vishesh Khanna, Shivaani Kummar, Raghad M Abdul-Karim, David Sommerhalder
Cancer Research Communications. 2024-09-01 - 2 citationsA Novel Framework for the Next Generation of Precision Oncology Targets.Christopher T Chen, James M Ford
JAMA Oncology. 2022-07-01 - Severe Lactic Acidosis Complicated by Insulin-Resistant Hyperosmolar Hyperglycemic Syndrome in a Patient With Metastatic Breast Cancer Undergoing AKT-Inhibitor Therapy.Maria I Stamou, Christopher Chen, Seth A Wander, Jeffrey G Supko, Dejan Juric
JCO Precision Oncology. 2022-06-01
Press Mentions
- James Van Der Beek’s Colon Cancer Diagnosis Highlights Alarming Trend in Young PeopleNovember 5th, 2024
- FDA Approves Blood Test for Colorectal Cancer Screening, What to KnowAugust 8th, 2024